Assessing disease activity in Crohn's disease--are we there yet?
Many attempts have been made over recent years to assess accurately disease activity in Crohn's disease. We review some of these attempts, giving particular emphasis to the combination of serum levels of proinflammatory cytokines (interleukin-6, tumour necrosis factor alpha, recombinant interleukin-2 and acid alpha-1-glycoprotein).
Eliakim
R
R
Department of Medicine, Hadassah University Hospital, Mount Scopus, Jerusalem, Israel.
Rachmilewitz
D
D
D015415:Biomarkers / Q000097:blood; D003424:Crohn Disease / Q000097:blood* / Q000503:physiopathology; D016207:Cytokines / Q000097:blood*; D006801:Humans; D007376:Interleukin-2 / Q000097:blood; D015850:Interleukin-6 / Q000097:blood; D014409:Tumor Necrosis Factor-alpha / Q000378:metabolism
D015415:Biomarkers; D016207:Cytokines; D007376:Interleukin-2; D015850:Interleukin-6; D014409:Tumor Necrosis Factor-alpha